Samsung Medical Center
Retinoblastoma treatment cost in South Korea typically includes essential diagnostics like an ophthalmologist consultation, which runs from Price on request to Price on request . Primary treatments such as cryotherapy range from AUD $9,482 to AUD $20,219, while HIFU costs AUD $17,430 to AUD $32,768. Prices depend on the clinic tier and disease stage, with patients saving 30–50% compared to Australia and the United States. Seoul remains the leading destination for this care.
Typical Retinoblastoma Treatment Costs in South Korea
Bookimed Expert Insight: Patients requiring advanced oncological care should consider Seoul National University Bundang Hospital. It was the first digital hospital in South Korea and uses the BESTcare system for precise data management. Families wanting multidisciplinary expertise often choose Severance Hospital, which holds JCI accreditation. JCI certification means the facility meets rigorous international safety standards for pediatric surgery. Larger centres like Samsung Medical Center handle over 45,000 operations annually, providing extensive experience in complex oncology cases.
| Republic of Korea | Thailand | Turkey | |
| High intensity focused ultrasound ablation (HIFU) | from AUD $17,430 | from AUD $11,852 | from AUD $5,578 |
| Chemotherapy for breast cancer | from AUD $26,773 | from AUD $4,183 | from AUD $1,673 |
| Cryotherapy | from AUD $9,482 | from AUD $4,462 | from AUD $349 |
| Radiation therapy for colorectal cancer | - | from AUD $7,669 | from AUD $9,761 |
| Photocoagulation | - | from AUD $837 | from AUD $349 |
No hidden fees – just official clinic prices. Pay at the clinic for Retinoblastoma treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Retinoblastoma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Retinoblastoma treatment journey.
South Korean medical centres report a patient survival rate of 95.5% for retinoblastoma. Success in early-stage cases (Groups A to C) reaches nearly 100% for eye preservation. Advanced cases now see 44.5% globe salvage rates due to intra-arterial chemotherapy (IAC) techniques at Seoul hospitals.
Bookimed Expert Insight: Retinoblastoma success here stems from aggressive adoption of localised delivery systems. Many countries rely on systemic chemo. However, Korean centres like Severance Hospital pioneered intra-arterial and intravitreal methods. These deliver drugs directly to the eye. This approach maintains high survival while dramatically increasing the chances of saving a child's sight.
Patient Consensus: Parents note that while survival is the priority, Korean teams often aim for eye preservation first. They suggest confirming the tumour stage early. Treatment goals differ significantly between early and advanced cases.
Republic of Korea offers advanced eye-saving treatments for retinoblastoma. Specialist centres prioritise focal therapies like cryotherapy and laser treatment to preserve vision. These institutions use proton beam therapy and intra-arterial chemotherapy. This helps avoid eye removal in many early-stage cases.
Bookimed Expert Insight: Samsung Medical Center and Severance Hospital have extensive experience. They handle over 40,000 surgeries each annually. Their partnerships with the Mayo Clinic and MD Anderson translate to better outcomes. Patients benefit from protocols used in the world's leading cancer hospitals.
Patient Consensus: Patients note that Korean clinicians prioritise eye-preserving methods like intra-arterial chemotherapy. They recommend bringing original pathology slides so the medical team can accurately confirm the diagnosis.